The demand for alpha emitter market is anticipated to increase significantly at a CAGR of 21% and reach a size of US$ 6.7 billion by the end of 2032, according to Fact.MR, a business that provides market research and competitive intelligence.
A substance that emits alpha rays is known as an alpha emitter. These compounds are produced by radioactive sources. They achieve the correct bio-distribution and related dose distribution to deliver effective therapy without resulting in severe short- or long-term side effects. The alpha particles used in medical operations are more corrosive to cancer cells than the beta particles because of their exceptionally high rates of cell death. Healthy tissues close by are not as seriously affected. Some radionuclides that are utilised in treatment include radium, lead, and bismuth.
Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7810?AS
Market Players
- Actinium Pharmaceuticals, Inc.
- Alpha Tau Medical
- Bayer AG
- Fusion Pharma
- IBA Group
- IBA Radiopharma Solutions
- Lantheus Medical Imaging, Inc.
- NTP Radiosotopes SOC Ltd.
- RadioMedix, Inc.
- Siemens Healthineers
- Telix Pharmaceuticals Ltd.
- Triad Isotopes, Inc.
Key partners in Market including industry players, policymakers, and financial backers in different nations have been persistently realigning their systems and ways to deal with carry out them to take advantage of new open doors. Numerous lately have updated their procedures to stay coordinated in the setting of overall disturbances brought about by the COVID-19 pandemic.
Key Takeaways from Market Study
- The global market for alpha emitters is currently valued at US$ 1 billion.
- Worldwide sales of alpha emitters are expected to reach US$ 6.7 billion by 2032.
- China’s alpha emitters market is expected to expand at a CAGR of 20% from 2022 to 2032.
- Demand for alpha emitters for ovarian cancer medical applications is predicted to rise at a CAGR of 22% from 2022 to 2032.
Rapid urbanization, ongoing healthcare infrastructure development, and rising disposable income levels, among others, are some of the key factors influencing market growth.
- The WHO report 2022 states that cancer is the biggest cause of mortality globally, accounting for approximately 10 million fatalities in 2020, or close to one in every six deaths.
- According to the same source, 400 000 youngsters are diagnosed with cancer each year.
- The eighth most common cancer in women and the 18th most prevalent cancer overall is ovarian cancer.
- The American Cancer Society predicts that 19,880 women will be newly diagnosed with ovarian cancer in the U.S. in 2022. Ovarian cancer will claim the lives of approximately 12,810 women.
Alpha emitters play an important role in killing cancerous cells using targeted therapy. Thus, the demand for alpha emitters is expected to rise at a significant rate over the coming years.
Winning Strategy
There are only a few significant companies in this less-competitive alpha emitters sector.
Actinium Pharmaceuticals, Inc., Alpha Tau Medical, Bayer AG, Fusion Pharma, Lantheus Medical Imaging, Inc., NTP Radiosotopes SOC Ltd., RadioMedix, Inc., Siemens Healthineers, and Triad Isotopes, Inc. are some of the key players in the alpha emitters market.
- A formal business merger agreement was signed by Healthcare Capital Corp. and Alpha Tau Medical Limited in July 2021. This deal is used to further Alpha Tau’s clinical plan, which includes pursuing FDA marketing permission, engaging in a wide range of R&D initiatives, increasing manufacturing capability, and getting ready for commercialization.
Industry Research
- By Type of Radionuclide:
- Radium
- Lead
- Bismuth
- Actinium
- By Application:
- Bone Metastasis
- Ovarian Cancer
- Pancreatic Cancer
- Melanoma
- Lymphoma
Analysis and Forecast by Region
- North America Alpha Emitters Market Size and Forecast, 2022-2032
- Germany Alpha Emitters Market Size and Forecast, 2022-2032
- UK Alpha Emitters Market Size and Forecast, 2022-2032
- France Alpha Emitters Market Size and Forecast, 2022-2032
- Spain Alpha Emitters Market Size and Forecast, 2022-2032
- Japan Alpha Emitters Market Size and Forecast, 2022-2032
- China Alpha Emitters Market Size and Forecast, 2022-2032
- Malaysia Alpha Emitters Market Size and Forecast, 2022-2032
- Thailand Alpha Emitters Market Size and Forecast, 2022-2032
- Australia Alpha Emitters Market Size and Forecast, 2022-2032
Get Customization on this Report for Specific Research Solutions –
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7810?AS
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : [email protected]